Ep. 209 Management of Bladder Cancer: Insights from Community Practice with Dr. Gautam Jayram

Are you a private practice urologist looking to build your bladder cancer service lines? In this episode of the BackTable Urology Podcast, Dr. Tom Jayram, urologist from Nashville joins host Dr. Aditya Bagrodia to discuss the latest advancements in non-muscle invasive bladder cancer treatment. The conversation focuses on the unique experiences and practical considerations in managing this complex condition in the community setting. --- This podcast is supported by: Ferring Pharmaceuticals https://www.ferring.com/home-classic/people-and-families/uro-uro-oncology/bladder-cancer/ --- SYNPOSIS The two urologic oncologists share their decision-making process for different therapies such as BCG, gemcitabine-doxorubicin, and Adstiladrin. The conversation also touches on the challenges of integrating new technologies into practice, managing the BCG shortage, and the role of multidisciplinary care. They discuss patient-centered care and the potential for personalized treatment plans. Finally, Dr. Jayram reflects on the lessons he has learned from his own practice, offering a unique insight into the differences between academic and community urology. --- TIMESTAMPS 00:00 - Introduction 04:47 - Community Practice and New Technologies 09:59 - Clinical Trials for Bladder Cancer Care 15:52 - Patient Referrals 29:27 - Exploring New Treatment Options 30:46 - Bladder Sparing Strategies 32:21 - BCG Treatment and Surveillance 47:04 - Implementation of New Therapies 54:27 - Future Directions --- RESOURCES Ferring Pharmaceuticals https://www.ferring.com/

There are no comments yet.

Please log in to write the first comment.